Auroora Yhtiöt Oyj (AUROORA.he) - Valuation
Auroora Yhtiöt Oyj valuation Helsinki OMXH


Target Price

For Q2 2026, the Target MCAP is 40 million Euros. For Q4 2027 (e), the Target MCAP is expected to increase to 165 million Euros, representing a change of 125 million Euros or 76% compared to the previous quarter.

Based on the forecast for the last reported Q2 2026 quarter, Auroora Yhtiöt Oyj receives SELL recommendation. Based on forecast for Q4 2027 (e) quarter, the stock receives BUY recommendation.

Valuation

Current market cap is 294.7 MEur (9.84 €) and the average MCap for the period is 225.3 MEur (7.5 €).



Current Enterprice Value is 316.4 MEur and the average EV for the period is 255.5 MEur. Expected EV at the end of the year for 2026 is 316.4 MEur and expected values for 2027 and 2028 are 328.6 MEur and 346.8 MEur.



Income Statement

Current Price to Sales ratio is 1.07 and the average realised P/S for the period is 0.9. Current P/S-ratio is +18.1 % higher than average value. Expected P/S at the end of the year for 2026 is 1.07 and expected values for 2027 and 2028 are 0.98 and 0.93.



Current Enterprice Value to Sales ratio is 1.15 and the average realised EV/S for the period is 1.03. Current EV/S-ratio is +11.1 % higher than average value. Expected EV/S at the end of the year for 2026 is 1.15 and expected values for 2027 and 2028 are 1.1 and 1.09.



Current EV/Ebit is 26.8. That is -14.0 % lower than average EV/Ebit 31.2 for positive values (<100). Expected EV/EBIT at the end of the year for 2026 is 26.8 and expected values for 2027 and 2028 are 19.8 and 13.3.



Current PE is 46.4. That is -25.1 % lower than average PE 61.9 for positive values (<100). Expected PE at the end of the year for 2026 is 46.4 and expected values for 2027 and 2028 are 22.2 and 14.1.



Shareholders Equity

Current Price to Book ratio is 2.71 and the average realised P/B for the period is 2.46. Current P/B-ratio is +10.1 % higher than average value. Expected P/B at the end of the year for 2026 is 2.71 and expected values for 2027 and 2028 are 2.42 and 2.06.

Cash Flow

Current P/OCF is 16.1. That is +4.8 % higher than average P/OCF 15.3 for positive values (<100). Expected P/OCF at the end of the year for 2026 is 16.1 and expected values for 2027 and 2028 are 19.4 and 32.6.



Current EV/OCF is 17.2. That is -2.4 % lower than average EV/OCF 17.7 for positive values (<100). Expected EV/OCF at the end of the year for 2026 is 17.2 and expected values for 2027 and 2028 are 21.6 and 38.3.



Current P/FCF on negative. The average P/OCF is 0 for positive values (<100). Expected P/FCF at the end of the year for 2026 is Neg. and expected values for 2027 and 2028 are Neg. and Neg..



Current EV/FCF on negative. The average EV/OCF is 0 for positive values (<100). Expected EV/FCF at the end of the year for 2026 is Neg. and expected values for 2027 and 2028 are Neg. and Neg..



Atria Oyj Biohit Oyj









Disclaimer

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.

Before deciding to trade in financial instrument you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.

The data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Contact: quant@quantfactory.eu

About Us